

Section 3. Terminology
[+] 14. Abbreviations
14.1 Academic Degrees, Certifications, and Honors.
[+] 14.2 US Military Services and Titles.
14.3 Days of the Week, Months, Eras.
14.4 Local Addresses.
14.5 Cities, States, Counties, Territories, Possessions; Provinces; Countries.
14.6 Names and Titles of Persons.
14.7 Business Firms.
14.8 Agencies and Organizations.
14.9 Collaborative Groups.
14.10 Names of Journals.
14.11 Clinical, Technical, and Other Common Terms.
14.12 Units of Measure.
14.13 Elements and Chemicals.
14.14 Radioactive Isotopes.
[+] 15. Nomenclature [+] 14.2 US Military Services and Titles.
14.3 Days of the Week, Months, Eras.
14.4 Local Addresses.
14.5 Cities, States, Counties, Territories, Possessions; Provinces; Countries.
14.6 Names and Titles of Persons.
14.7 Business Firms.
14.8 Agencies and Organizations.
14.9 Collaborative Groups.
14.10 Names of Journals.
14.11 Clinical, Technical, and Other Common Terms.
14.12 Units of Measure.
14.13 Elements and Chemicals.
14.14 Radioactive Isotopes.
[+] 15.1 Blood Groups, Platelet Antigens, and Granulocyte Antigens.
[+] 15.2 Cancer
[+] 15.6 Genetics.
15.13 Ophthalmology Terms.
[+] 15.14 Organisms and Pathogens
[+] 15.17 Radiology Terms
[+] 16. Eponyms [+] 15.2 Cancer
15.2.1 Cancer Stage.
15.2.2 The TNM Staging System.
15.2.3 Bethesda System.
15.2.4 Multiple Endocrine Neoplasia.
15.2.5 Molecular Cancer Terminology
[+] 15.3 Cardiology.15.2.2 The TNM Staging System.
15.2.3 Bethesda System.
15.2.4 Multiple Endocrine Neoplasia.
15.2.5 Molecular Cancer Terminology
15.3.1 Electrocardiographic Terms.
15.3.2 Electrograms.
15.3.3 Heart Sounds.
15.3.4 Murmurs.
15.3.5 Jugular Venous Pulse.
15.3.6 Echocardiography.
15.3.7 Pacemaker Codes.
15.3.8 Implanted Cardioverter/Defibrillators.
15.3.9 Pacemaker-Lead Code.
15.3.10 Heart Disease Classifications.
15.3.11 Coronary Artery Angiographic Classifications.
15.3.12 Cellular and Molecular Cardiology.
[+] 15.4 Drugs. 15.3.2 Electrograms.
15.3.3 Heart Sounds.
15.3.4 Murmurs.
15.3.5 Jugular Venous Pulse.
15.3.6 Echocardiography.
15.3.7 Pacemaker Codes.
15.3.8 Implanted Cardioverter/Defibrillators.
15.3.9 Pacemaker-Lead Code.
15.3.10 Heart Disease Classifications.
15.3.11 Coronary Artery Angiographic Classifications.
15.3.12 Cellular and Molecular Cardiology.
15.4.1 The Drug Development and Approval Process.
15.4.2 Nonproprietary Names.
15.4.3 Proprietary Names
15.4.4 Chemical Names.
15.4.5 Code Designations.
15.4.6 Trivial Names.
15.4.7 Drugs With Inactive Components.
15.4.8 Stereoisomers.
15.4.9 Combination Products.
15.4.10 Drug Preparation Names That Include a Percentage.
15.4.11 Multiple-Drug Regimens.
15.4.12 Drug Abbreviations.
15.4.13 Nomenclature for Biological Products.
15.4.14 Vitamins and Related Compounds.
15.4.15 Herbals and Dietary Supplements.
15.5 Equipment, Devices, and Reagents. 15.4.2 Nonproprietary Names.
15.4.3 Proprietary Names
15.4.4 Chemical Names.
15.4.5 Code Designations.
15.4.6 Trivial Names.
15.4.7 Drugs With Inactive Components.
15.4.8 Stereoisomers.
15.4.9 Combination Products.
15.4.10 Drug Preparation Names That Include a Percentage.
15.4.11 Multiple-Drug Regimens.
15.4.12 Drug Abbreviations.
15.4.13 Nomenclature for Biological Products.
15.4.14 Vitamins and Related Compounds.
15.4.15 Herbals and Dietary Supplements.
[+] 15.6 Genetics.
15.6.1 Nucleic Acids and Amino Acids.
15.6.2 Human Gene Nomenclature.
15.6.3 Oncogenes and Tumor Suppressor Genes
15.6.4 Human Chromosomes
15.6.5 Nonhuman Genetic Terms.
15.6.6 Pedigrees.
[+] 15.7 Hemostasis. 15.6.2 Human Gene Nomenclature.
15.6.3 Oncogenes and Tumor Suppressor Genes
15.6.4 Human Chromosomes
15.6.5 Nonhuman Genetic Terms.
15.6.6 Pedigrees.
15.7.1 Primary Hemostasis.
15.7.2 Endothelial Factors.
15.7.3 Secondary Hemostasis.
15.7.4 Inhibition of Coagulation and Fibrinolysis
[+] 15.8 Immunology 15.7.2 Endothelial Factors.
15.7.3 Secondary Hemostasis.
15.7.4 Inhibition of Coagulation and Fibrinolysis
15.8.1 Chemokines.
15.8.2 CD Cell Markers.
15.8.3 Complement.
15.8.4 Cytokines.
15.8.5 HLA/Major Histocompatibility Complex.
15.8.6 Immunoglobulins.
15.8.7 Lymphocytes.
[+] 15.9 Isotopes. 15.8.2 CD Cell Markers.
15.8.3 Complement.
15.8.4 Cytokines.
15.8.5 HLA/Major Histocompatibility Complex.
15.8.6 Immunoglobulins.
15.8.7 Lymphocytes.
15.9.1 Elements.
15.9.2 Radiopharmaceuticals.
15.9.3 Radiopharmaceutical Compounds Without Approved Names.
15.9.4 Radiopharmaceutical Proprietary Names.
15.9.5 Uniform Labeling.
15.9.6 Hydrogen Isotopes.
15.9.7 Metastable Isotopes.
[+] 15.10 Molecular Medicine. 15.9.2 Radiopharmaceuticals.
15.9.3 Radiopharmaceutical Compounds Without Approved Names.
15.9.4 Radiopharmaceutical Proprietary Names.
15.9.5 Uniform Labeling.
15.9.6 Hydrogen Isotopes.
15.9.7 Metastable Isotopes.
15.10.1 Molecular Terminology: Other Sections of Chapter 15.
15.10.2 Molecular Terms: Considerations and Examples.
15.10.3 Enzyme Nomenclature.
[+] 15.11 Neurology 15.10.2 Molecular Terms: Considerations and Examples.
15.10.3 Enzyme Nomenclature.
15.11.1 Nerves.
15.11.2 Electroencephalographic Terms.
15.11.3 Evoked Potentials.
15.11.4 Polysomnography and Sleep Stages.
15.11.5 Molecular Neuroscience.
[+] 15.12 Obstetric Terms. 15.11.2 Electroencephalographic Terms.
15.11.3 Evoked Potentials.
15.11.4 Polysomnography and Sleep Stages.
15.11.5 Molecular Neuroscience.
15.13 Ophthalmology Terms.
[+] 15.14 Organisms and Pathogens
15.14.1 Biological Nomenclature
15.14.2 Bacteria: Additional Terminology
15.14.3 Virus Nomenclature.
15.14.4 Prions.
[+] 15.15 Psychiatric Terminology. 15.14.2 Bacteria: Additional Terminology
15.14.3 Virus Nomenclature.
15.14.4 Prions.
15.15.1 Diagnostic and Statistical Manual of Mental Disorders (DSM).
15.15.2 Other Psychiatric Terminology.
[+] 15.16 Pulmonary, Respiratory, and Blood Gas Terminology. 15.15.2 Other Psychiatric Terminology.
[+] 15.17 Radiology Terms
[+] 17. Greek Letters
17.1 Greek Letter vs Word.
17.2 Capitalization After a Greek Letter.
17.3 Greek Alphabet.
17.4 Page Composition and Electronic Formats.
17.2 Capitalization After a Greek Letter.
17.3 Greek Alphabet.
17.4 Page Composition and Electronic Formats.




TOP